Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mimetogen Pharmaceuticals USA, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be at least 18 years of age.
Provided written informed consent.
Have a reported history of dry eye Have a history of use or desire to use eye drops for dry eye
You may not be if
Be diagnosed with an ongoing ocular infection (bacterial, viral, or fungal) at Visit 1.
Be diagnosed with ocular rosacea, or any viral or bacterial disease of the cornea or conjunctiva, within the last 12 months.
Have any planned ocular and/or lid surgeries over the study period.
Have corrected visual acuity greater than or equal to +0.7 as assessed by Early Treatment of Diabetic Retinopathy Study (ETDRS) scale in both eyes at Visit .
Have an uncontrolled systemic disease.
Be a woman who is pregnant, nursing or planning a pregnancy.
Be a woman of childbearing potential who is not using an acceptable means of birth control
Have a known allergy and/or sensitivity to the test article or its components.
Have a condition or be in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 45 days of Visit 1 Be unable or unwilling to follow instructions, including participation in all study assessments and visits
Clareo Health | A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
